The nation has seen an influx of investment from Canadian cannabis companies, set in motion by its previous president. Will a new administration keep the momentum?
Lawmakers could undo Prop 2 — and threat of litigation looms.
As legislative priorities shift, what is gained? And what is lost?
Cannabis companies are increasingly lobbying and handing out campaign contributions on both sides of the aisle.
The cannabis debate in Congress is being reshaped along GOP-friendly lines.
A burgeoning industry is using its money to influence politics, and finding new GOP allies in the process. But there may be a price.
On Election Day, three of four cannabis voter measures passed. And dozens of congressional, gubernatorial, and local results have implications for the future of cannabis in the US.
As cities across the state continue to draft their own rules for home cultivation, this ruling in Fontana could serve as a precedent.
Case by case, a team of lawyers chips away at prohibition, and a new president may soon take a swing.
Here's what voters should know about the dark money and wealthy backers behind two of them—and the promises of all three.